FDA Approves Argenx’s Vyvgart To Treat Myasthenia Gravis

The U.S. Food and Drug Administration has granted approval for argenx BV’s Vyvgart (efgartigimod) for the treatment of generalized myasthenia gravis or gMG in adults who test positive for the anti-acetylcholine receptor (AChR) antibody. Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles, also […]

» Read more

Sensex crashes over 1,500 points over Omicron fears

The overall breadth was also extremely negative, with nearly 5 declining stocks versus a advancing share on the BSE. The key benchmark indices continued to languish near the lows on Monday, tracking across-the-board losses amid a selloff in global markets as concerns over rising Omicron cases spooked investors. Persistent foreign […]

» Read more
1 206 207 208 209 210 523